| Autor: |
Ying-chao Peng, Zhi-qiang Zhang, Mei-qiu Wang, Xiang Fang, Chun-lin Gao, Tao Sun, Zheng-kun Xia |
| Jazyk: |
čínština |
| Rok vydání: |
2024 |
| Předmět: |
|
| Zdroj: |
Linchuang shenzangbing zazhi, Vol 24, Iss 2, Pp 108-115 (2024) |
| Druh dokumentu: |
article |
| ISSN: |
1671-2390 |
| DOI: |
10.3969/j.issn.1671-2390.2024.02.004 |
| Popis: |
ObjectiveTo evaluate the efficacy and safety of rituximab (RTX) for steroid-resistant idiopathic focal segmental glomerulosclerosis (FSGS) in children.MethodsFrom 2014 to 2020, the relevant clinical data were retrospectively reviewed for 12 children of steroid-resistant idiopathic FSGS .ResultsSteroid resistance was initial (n=10) and delayed (n=2). The age of initial RTX dosing was 8.00(5.15, 15.25) years. During a follow-up period of 6 months, complete remission (CR, n=3,) and partial remission (PR, n=1) were obtained. At the last follow-up, there were CR (n=1) and PR (n=2). Remission rate was higher in children on ≥3 doses than in those on |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
